Syros Pharmaceuticals (SYRS)

Syros Pharmaceuticals (SYRS) – Analyst Ratings

Jun 8, 2022 06:17 AM "There is Upside to Market Potential and Our Outlook" of SY-1425 - Brookline Capital Markets Bullish on Syros Pharmaceuticals (SYRS) with Buy Rating and $19 Price Target
May 17, 2022 06:44 AM Oppenheimer Reiterates Outperform Rating, $9 Price Target on Syros Pharmaceuticals (SYRS), "Investors Can Look Forward to Multiple Catalysts"
Apr 12, 2022 05:55 AM
Mar 16, 2022 06:33 AM
Jan 3, 2022 08:01 AM
Sep 23, 2021 08:27 AM
Sep 21, 2021 06:19 AM
Nov 10, 2020 07:39 AM
Nov 4, 2020 07:40 AM
Apr 23, 2020 07:28 AM
Jan 17, 2020 06:57 AM
Jul 12, 2019 02:16 PM
Apr 10, 2019 09:19 AM
Mar 8, 2019 03:18 AM
Feb 14, 2019 08:07 AM
Nov 5, 2018 07:31 AM
Feb 5, 2018 06:08 AM
Oct 31, 2017 04:20 AM
Oct 23, 2017 07:33 AM
Sep 28, 2017 04:40 AM
Aug 10, 2017 05:01 AM
Apr 10, 2017 09:41 AM
Nov 28, 2016 04:07 PM
Jul 25, 2016 07:11 AM
Jul 25, 2016 06:58 AM
Jul 25, 2016 06:57 AM
Jul 25, 2016 06:41 AM
Jul 18, 2016 07:48 AM